Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Efficacy of Omeza® Complete Matrix in the Healing of Chronic Diabetic Foot Ulcers: A Randomized Controlled Multicenter Crossover Trial

NCT07161830 is registered in ClinicalTrials.gov with Omeza, LLC as lead sponsor.

NCT NCT07161830
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07161830 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Efficacy of Omeza® Complete Matrix in the Healing of Chronic Diabetic Foot Ulcers: A Randomized Controlled Multicenter Crossover Trial
Lead sponsor
Omeza, LLC
Phase
Not applicable
Overall status
Recruiting
Start date
December 4, 2025
Completion date
March 30, 2027
Enrollment
180 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic foot ulcer